Tag Archives: Pharmaceutical

Medical Cannabis Symposium

Khiron Appoints Former DEA Chief of Pharmaceutical Investigations to Advisory Board

Khiron Appoints Former DEA Chief of Pharmaceutical Investigations to Advisory Board

ORONTO, Ontario, Sept. 29, 2017 /Weed Wire/ — Khiron Life Sciences Corp. (“Khiron” or the “Company”) reports the appointment of Mr. Matthew Murphy, the former U.S. Drug Enforcement Administration (“DEA”) Chief of Pharmaceutical Investigations, to the Advisory Board of the Company.

Tetra Bio-Pharma Its Position

Tetra Bio-Pharma Strengthens its Position on Bringing Marijuana to Patients in a Form Acceptable to Health Care Professionals

OTTAWA, Ontario, July 5, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(CSE:TBP.CN)(CNSX:TBP)(OTCQB:TBPMF), today announced that it has strengthened its position on bringing marijuana to patients in the form of a prescription drug.

Sean Murphy Weighs in on the Future of Medical Cannabis

Sean Murphy Weighs in on the Future of Medical Cannabis

At the California Cannabis Business Expo on March 8, 2017, entrepreneurs and investors interested in the science and technology of medical cannabis were given a crash course in the future of cannabis, and cannabidiol, as an alternative to pharmaceuticals by Hemp Business Journal founder Sean Murphy.

OWC Pharmaceutical

OWC Pharmaceutical Research Announces the Promising Results of Phase Lab Testing for Multiple Myeloma

PETACH TIKVA, Israel, October 20, 2016 /Weed Wire/ — OWC Pharmaceutical Research Corp. (OTCQB: OWCP), (“OWC” or the “Company”) today announced that it has completed the development of a proprietary, cannabinoid-enriched sublingual tablet (the “Tablet”) for the administration of medical cannabis.


Columbia Care Introduces the Nation’s First Controlled-Dose, Solid-Fill Medical Cannabinoid Capsules

NEW YORK, Oct. 20, 2016 /Weed Wire/ — Columbia Care LLC (“CC”), a leading national medical marijuana product development, manufacturing and distribution company, today announced the launch of its line of controlled-dose, solid-fill medical cannabinoid capsules.

Exclusive: GW Pharmaceuticals Hires Investment Bank Following Approaches - Sources

Exclusive: GW Pharmaceuticals Hires Investment Bank Following Approaches – Sources

GW Pharmaceuticals Plc (Nasdaq:GWPH), a developer of marijuana-based epilepsy treatments, is working with an investment bank after other drugmakers approached it to express interest in an acquisition, people familiar with the matter said.

Department of Consumer Protection Commends State Legislature for Passing Medical Marijuana Access for Patients Under 18

HARTFORD, Conn., May 2, 2016 /Weed Wire/ — On Friday, HB 5450 passed the State Senate after passing the House on April 20th. The Department of Consumer Protection commends the members of the legislature who supported this thoughtful expansion of Connecticut’s medical marijuana program.

Sage Analytics Financing and El Camino Ave Dispensary

Sage Analytics Announces New Data Storage Feature on The Beacon Cannabis Testing System

LAS VEGAS, Nev., Nov. 4, 2015 /Weed Wire/ — Sage Analytics, the developers of a new generation of portable, laboratory-quality cannabis potency measurement systems, announced that it will unveil significant new features and improvements to the Beacon™ at the Marijuana Business Conference and Expo in Las Vegas.

Public Companies

Will the Marijuana Market Continue to Go Public?

There are several different schools of thought within the industry and investment community on which companies make better if not lower risk investments, as well as which companies in the still-developing market are likely to go public first.

Zynerba IPO

Zynerba IPO a Big $275 Million Entry for Cannabinoids

It has been a bit of a dry spell for decent IPOs in the cannabis space. But the rains have come down with the initial public offering of Devon, Pennsylvania-based Zynerba Pharmaceuticals (NASDAQ: ZYNE).

Massachusetts Cannabis Research Labs

Massachusetts Cannabis Research Labs is the only ISO-17025 accredited medical marijuana testing laboratory located on the East Coast. MCR Labs offers quality assurance in testing all MMJ products, marijuana buds as well as MIP’s. The laboratory utilizes methodologies from the pharmaceutical industry to further improve marijuana test accuracy and lower costs.